Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Different Types of Cancer”

302 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 302 results

Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Testing effectiveness (Phase 2)Study completedNCT00412425
What this trial is testing

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT04353050
What this trial is testing

Atypical MOLes and Melanoma Early Detection Study (MoleMed)

Who this might be right for
MelanomaMelanoma (Skin)Moles+9 more
Russian Academy of Medical Sciences 350
Early research (Phase 1)Study completedNCT06056024
What this trial is testing

Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Who this might be right for
Solid Tumor, KRAS Mutation
Boehringer Ingelheim 47
Early research (Phase 1)Active Not RecruitingNCT05068102
What this trial is testing

Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim 14
Testing effectiveness (Phase 2)Study completedNCT00060944
What this trial is testing

Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Who this might be right for
LiposarcomaLeiomyosarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Not applicableLooking for participantsNCT07514052
What this trial is testing

Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study

Who this might be right for
Multiple Myeloma of Bone
Shanxi Bethune Hospital 127
Not applicableNot Yet RecruitingNCT07158892
What this trial is testing

Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test

Who this might be right for
Non-traumatic Musculoskeletal ConditionsCarpal Tunnel Syndrome (CTS)Lateral Epicondylitis+5 more
University of Texas at Austin 220
Not applicableStudy completedNCT03147365
What this trial is testing

Effect of Different Exercises on Quality of Life of Leukemia Patients.

Who this might be right for
Quality of LifeAcute Lymphoblastic LeukemiaExercise
Children's Cancer Hospital Egypt 57357 75
Not applicableStudy completedNCT03581045
What this trial is testing

Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals

Who this might be right for
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 92
Not applicableStudy completedNCT04250402
What this trial is testing

The Incidence of Gallstones After Gastric Cancer Surgery

Who this might be right for
GallstonesGastric Cancer
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,019
Testing effectiveness (Phase 2)Looking for participantsNCT06324357
What this trial is testing

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Who this might be right for
Metastatic Breast CancerMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Boehringer Ingelheim 768
Testing effectiveness (Phase 2)Study completedNCT05978739
What this trial is testing

Evaluating Different Doses of Orelabrutinib in MCL

Who this might be right for
Mantle Cell Lymphoma
InnoCare Pharma Inc. 40
Early research (Phase 1)Active Not RecruitingNCT04111458
What this trial is testing

Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)

Who this might be right for
Solid Tumors, KRAS Mutation; SOS1
Boehringer Ingelheim 71
Testing effectiveness (Phase 2)Study completedNCT00010179
What this trial is testing

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 81
Not applicableStudy completedNCT03047603
What this trial is testing

Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 4,005
Early research (Phase 1)Looking for participantsNCT05471856
What this trial is testing

Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Who this might be right for
Solid Tumors
Boehringer Ingelheim 66
Testing effectiveness (Phase 2)Looking for participantsNCT07227311
What this trial is testing

Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 200
Early research (Phase 1)Study completedNCT04147234
What this trial is testing

Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)

Who this might be right for
Neoplasms
Boehringer Ingelheim 42
Not applicableUnknownNCT01247506
What this trial is testing

Different Genetic Features Associated With Hepatic Carcinogenesis

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 160
Next Page